Efficacy of Tele-CPASS Compared to In-person CPASS Therapy for Upper Extremity Motor Recovery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorUniversity of Texas, El Paso

About this trial

This study evaluates whether a home-based telerehabilitation program (tele-CPASS) is as effective as an in-person rehabilitation program (CPASS) for improving arm and hand function after stroke. Stroke often leads to long-term difficulty using the affected arm in daily activities, and access to in-person therapy can be limited. This study aims to determine whether therapy delivered remotely can provide similar benefits to standard in-clinic care.

Participants who recently experienced a stroke will be randomly assigned to receive 20 hours of upper extremity rehabilitation therapy either in person or through a telehealth platform. Both groups will receive the same type and amount of therapy focused on practicing meaningful, patient-selected daily activities. Participants will complete assessments before treatment, immediately after treatment, and at 6 and 12 months to measure recovery of arm function, real-world arm use, and participation in daily life.

The results of this study will help determine whether telerehabilitation can improve access to effective stroke recovery interventions while maintaining clinical effectiveness comparable to in-person therapy.

Eligibility criteria

Qualifiers

Age 21 years or older

Neuroimaging-confirmed stroke within 40 days prior to enrollment

Persistent hemiparesis resulting in impaired upper extremity function, defined by a score of 0 to 3 on the NIH Stroke Scale motor arm item

Able to participate in all study-related activities, including 1-year follow-up

Disqualifiers

Inability to provide informed consent

Persistent disabling neurologic condition, such as multiple sclerosis, Parkinsonism, amyotrophic lateral sclerosis, or dementia requiring medication

Clinically significant fluctuations in mental status within 72 hours prior to randomization

Active psychosis, psychosis within the prior 2 years, active substance abuse, or prior substance abuse

Trial design

Treatments tested in this trial

  • Tele-CPASS
  • In-person CPASS therapy

Treatment groups

42 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Texas, El Paso

Lead sponsor

Texas Tech University Health Sciences Center, El Paso

Collaborator

The Catholic University of America

Collaborator